Buch
Resistance to Molecular Therapies for Hepatocellular Carcinoma
Augusto Villanueva (Hrsg.)
160,49
EUR
Lieferzeit 12-13 Tage
Übersicht
Verlag | : | Springer International Publishing |
Buchreihe | : | Resistance to Targeted Anti-Cancer Therapeutics (Bd. 13) |
Sprache | : | Englisch |
Erschienen | : | 02. 08. 2018 |
Seiten | : | 147 |
Einband | : | Kartoniert |
Höhe | : | 235 mm |
Breite | : | 155 mm |
Gewicht | : | 260 g |
ISBN | : | 9783319858500 |
Sprache | : | Englisch |
Autorinformation
Augusto Villanueva, MD, PhD, is Assistant Professor, Division of Liver Diseases, Liver Cancer Program, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine, NYC.
Inhaltsverzeichnis
Tumor Heterogeneity and Resistance to Targeted Therapies in Hepatocellular Carcinoma.- Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma.- Role of Tumor Microenvironment in Hepatocellular Carcinoma Resistance.- Contribution of the Cancer Stem Cell Phenotype to Hepatocellular Carcinoma Resistance.- Clinical and Preclinical Perspectives on Mechanisms  of Sorafenib Resistance in Hepatocellular Carcinoma.- Radiological Assessment of Response to Palliative Treatments in Hepatocellular Carcinoma.- Sorafenib and Clinical Patterns of Resistance in hepatocellular carcinoma.- Overcoming Treatment Resistance in Hepatocellular Carcinoma: regorafenib and lessons from other malignancies.